Empowering Communities,
Improving Health Outcomes
European African Treatment Advocates Network (EATAN) is a Europe-wide Network that aims to enhance the quality of migrant communities in UK,Europe ,East&southern Africa and in particular Africans living with or at risk of Covid19,Ebola HIV, viral hepatitis, TB and other chronic conditions.
2018 European African HIV/AIDS & Hepatitis C Community Summit 21-22 July 2018
EATAN has identified a series of factors that negatively impact upon the ability of Africans living in Europe to prevent, diagnose, monitor and successfully treat communicable and chronic conditions; and in response we have constructed a set of recommendations to promote at European governmental level in order to assist Africans living in Europe to achieve happy, healthy and fulfilling lives.
For the individual patient living with a communicable or chronic condition, starting and adhering to treatment is paramount to slow disease progression, avert further damage to the body and can enable them to achieve happy, healthy and fulfilling lives.
For Migrants living in Europe and those working with migrants in teh field of HIV, Hepatitis, TB or any other chronic conditions so as to enhance access to testing, treatment and care.
EATAN is dedicated to developing a diverse membership of people from across Europe and beyond.
EATAN is dedicated to extending our policy of equal opportunity to our staff, volunteers and members.
M-Care - Mobilizing Migrant Communities via Capacity and Access Resource Development is a training programme that is jointly organised by the European AIDS Treatment Group (EATG) and the European African Treatment Advocates Network (EATAN). The training that took place in Brussels, on 10-14 November 2016.
In Europe there are a number of causes for stigma and discrimination directed at Migrants and in particular patients of African backgorund living in Europe who have HIV, viral Hepatitis or TB.
EATAN’s Online Patient Forum, we provide a safe space that encourages Migrants living in Europe to describe their experiences of transmission, screening, monitoring and treatment adherence surrounding HIV, viral Hepatitis and TB.